华邦健康(002004) - 2017 Q1 - 季度财报

Revenue and Profit - The company's revenue for Q1 2017 was ¥2,024,574,397.93, representing a 33.92% increase compared to ¥1,511,801,334.50 in the same period last year[7] - Net profit attributable to shareholders decreased by 15.77% to ¥145,049,990.77 from ¥172,211,196.21 year-on-year[7] - Revenue for Q1 2017 reached CNY 2,024,574,397.93, an increase of 33.92% compared to CNY 1,511,801,334.50 in Q1 2016, primarily due to increased sales volume[15] - The net profit for the first quarter of 2017 was CNY 168,073,401.33, a decrease from CNY 188,118,811.92 in the same period last year, representing a decline of approximately 10.5%[33] - The total profit for the first quarter of 2017 was CNY 190,002,684.28, compared to CNY 211,340,235.44 in the previous year, reflecting a decrease of approximately 10%[33] Cash Flow - The net cash flow from operating activities increased significantly by 156.71% to ¥405,659,959.83, up from ¥158,022,363.10 in the previous year[7] - Cash flow from operating activities in Q1 2017 was CNY 405,659,959.83, a significant increase of 156.71% from CNY 158,022,363.10 in Q1 2016, attributed to improved collection efforts[15] - The cash inflow from operating activities for the first quarter of 2017 was CNY 2,062,769,377.98, up from CNY 1,515,675,120.52 in the previous year, representing an increase of about 36%[40] - The net cash flow from operating activities for the first quarter was CNY 405,659,959.83, a significant increase from CNY 158,022,363.10 in the previous year, representing a growth of approximately 156.5%[41] - The company experienced a net increase in cash and cash equivalents of CNY -174,707,103.65, compared to CNY -1,327,864,123.39 in the previous year, indicating an improvement in cash management[42] Assets and Liabilities - Total assets at the end of the reporting period were ¥25,155,259,718.78, a 3.83% increase from ¥24,227,883,836.43 at the end of the previous year[7] - Total assets as of March 31, 2017, amounted to CNY 25,155,259,718.78, compared to CNY 24,227,883,836.43 at the beginning of the year[25] - The total liabilities as of the end of Q1 2017 amounted to CNY 14,275,744,702.36, compared to CNY 13,523,639,972.64 at the beginning of the year, representing an increase of 5.6%[27] - The company's total equity attributable to shareholders was CNY 9,795,894,865.36, an increase from CNY 9,645,235,055.95, reflecting a growth of 1.6%[27] - Short-term borrowings increased to CNY 5,980,738,721.09 from CNY 5,140,126,463.20, indicating a rise in financing activities[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 122,656[11] - The largest shareholder, Tibet Huibang Technology Co., Ltd., held 13.18% of the shares, amounting to 268,203,705 shares[11] Earnings Per Share - Basic and diluted earnings per share both decreased by 12.50% to ¥0.07 from ¥0.08 in the same period last year[7] - The basic and diluted earnings per share for the first quarter of 2017 were both CNY 0.07, down from CNY 0.08 in the same period last year[34] Investment and Financial Activities - The company reported non-recurring gains and losses totaling ¥2,429,380.56 for the period[8] - Investment income for Q1 2017 was CNY 61,618,279.77, a 57.78% increase from CNY 39,053,633.69 in Q1 2016, driven by higher profits from invested units[15] - Financial expenses for Q1 2017 were CNY 114,966,450.64, up 60.94% from CNY 71,434,539.79 in Q1 2016, reflecting increased interest expenses due to higher financing scale[15] - The company did not engage in any repurchase transactions during the reporting period[12]